Muna Sapkota1, Ellen L Burnham2, Jane M DeVasure3, Jenea M Sweeter3, Carlos D Hunter4, Michael J Duryee4, Lynell W Klassen4, Kusum K Kharbanda5, Joseph H Sisson3, Geoffrey M Thiele4, Todd A Wyatt1,3,5. 1. Department of Environmental, Agricultural and Occupational Health, University of Nebraska Medical Center, Omaha, Nebraska. 2. University of Colorado School of Medicine, Anschutz Medical Campus, Denver, Colorado. 3. Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska. 4. Division of Rheumatology and Immunology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska. 5. VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska.
Abstract
BACKGROUND: Malondialdehyde (MDA) and acetaldehyde (AA) exist following ethanol metabolism and tobacco pyrolysis. As such, lungs of individuals with alcohol use disorders (AUDs) are a target for the effects of combined alcohol and cigarette smoke metabolites. MDA and AA form a stable protein adduct, malondialdehyde-acetaldehyde (MAA) adduct, known to be immunogenic, profibrotic, and proinflammatory. MAA adduct is the dominant epitope in anti-MAA antibody formation. We hypothesized that MAA-adducted protein forms in lungs of those who both abuse alcohol and smoke cigarettes, and that this would be associated with systemically elevated anti-MAA antibodies. METHODS: Four groups were established: AUD subjects who smoked cigarettes (+AUD/+smoke), smokers without AUD (-AUD/+smoke), AUD without smoke (+AUD/-smoke), and non-AUD/nonsmokers (-AUD/-smoke). RESULTS: We observed a significant increase in MAA adducts in lung cells of +AUD/+smoke versus -AUD/-smoke. No significant increase in MAA adducts was observed in -AUD/+smoke or in +AUD/-smoke compared to -AUD/-smoke. Serum from +AUD/+smoke had significantly increased levels of circulating anti-MAA IgA antibodies. After 1 week of alcohol that MAA-adducted protein is formed in the lungs of those who smoke cigarettes and abuse alcohol, leading to a subsequent increase in serum IgA antibodies. CONCLUSIONS: MAA-adducted proteins could play a role in pneumonia and other diseases of the lung in the setting of AUD and smoking.
BACKGROUND:Malondialdehyde (MDA) and acetaldehyde (AA) exist following ethanol metabolism and tobacco pyrolysis. As such, lungs of individuals with alcohol use disorders (AUDs) are a target for the effects of combined alcohol and cigarette smoke metabolites. MDA and AA form a stable protein adduct, malondialdehyde-acetaldehyde (MAA) adduct, known to be immunogenic, profibrotic, and proinflammatory. MAA adduct is the dominant epitope in anti-MAA antibody formation. We hypothesized that MAA-adducted protein forms in lungs of those who both abuse alcohol and smoke cigarettes, and that this would be associated with systemically elevated anti-MAA antibodies. METHODS: Four groups were established: AUD subjects who smoked cigarettes (+AUD/+smoke), smokers without AUD (-AUD/+smoke), AUD without smoke (+AUD/-smoke), and non-AUD/nonsmokers (-AUD/-smoke). RESULTS: We observed a significant increase in MAA adducts in lung cells of +AUD/+smoke versus -AUD/-smoke. No significant increase in MAA adducts was observed in -AUD/+smoke or in +AUD/-smoke compared to -AUD/-smoke. Serum from +AUD/+smoke had significantly increased levels of circulating anti-MAAIgA antibodies. After 1 week of alcohol that MAA-adducted protein is formed in the lungs of those who smoke cigarettes and abuse alcohol, leading to a subsequent increase in serum IgA antibodies. CONCLUSIONS:MAA-adducted proteins could play a role in pneumonia and other diseases of the lung in the setting of AUD and smoking.
Authors: G M Thiele; D J Tuma; M S Willis; J A Miller; T L McDonald; M F Sorrell; L W Klassen Journal: Alcohol Clin Exp Res Date: 1998-11 Impact factor: 3.455
Authors: Derrick T Antoniak; Michael J Duryee; Ted R Mikuls; Geoffrey M Thiele; Daniel R Anderson Journal: Free Radic Biol Med Date: 2015-11-04 Impact factor: 7.376
Authors: Michael L McCaskill; Kusum K Kharbanda; Dean J Tuma; Jill D Reynolds; Jane M DeVasure; Joseph H Sisson; Todd A Wyatt Journal: Alcohol Clin Exp Res Date: 2011-03-23 Impact factor: 3.455
Authors: Michael J Duryee; Thomas L Freeman; Monte S Willis; Carlos D Hunter; Bartlett C Hamilton; Hiroshi Suzuki; Dean J Tuma; Lynell W Klassen; Geoffrey M Thiele Journal: Mol Pharmacol Date: 2005-08-16 Impact factor: 4.436
Authors: Kristina L Bailey; Debra J Romberger; Dawn M Katafiasz; Art J Heires; Joseph H Sisson; Todd A Wyatt; Ellen L Burnham Journal: Alcohol Clin Exp Res Date: 2015-07-24 Impact factor: 3.455
Authors: Ted R Mikuls; Rohit Gaurav; Geoffrey M Thiele; Bryant R England; Madison G Wolfe; Brianna P Shaw; Kristina L Bailey; Todd A Wyatt; Amy J Nelson; Michael J Duryee; Carlos D Hunter; Dong Wang; Debra J Romberger; Dana P Ascherman; Jill A Poole Journal: Int Immunopharmacol Date: 2021-08-27 Impact factor: 4.932
Authors: Claire G Nissen; Deanna D Mosley; Kusum K Kharbanda; Dawn M Katafiasz; Kristina L Bailey; Todd A Wyatt Journal: Front Immunol Date: 2022-05-20 Impact factor: 8.786
Authors: Sicong Huang; Vanessa L Kronzer; Paul F Dellaripa; Kevin D Deane; Marcy B Bolster; Vivek Nagaraja; Dinesh Khanna; Tracy J Doyle; Jeffrey A Sparks Journal: Curr Treatm Opt Rheumatol Date: 2020-09-01
Authors: Todd A Wyatt; Kristi J Warren; Tanner J Wetzel; Troy Suwondo; Gage P Rensch; Jane M DeVasure; Deanna D Mosley; Kusum K Kharbanda; Geoffrey M Thiele; Ellen L Burnham; Kristina L Bailey; Samantha M Yeligar Journal: Am J Pathol Date: 2021-06-27 Impact factor: 5.770
Authors: Carmen A Ochoa; Claire G Nissen; Deanna D Mosley; Christopher D Bauer; Destiny L Jordan; Kristina L Bailey; Todd A Wyatt Journal: Biomolecules Date: 2022-03-02